FDA NDC Directory · JSON-LD · Markdown

Hyoscyamine Sulfate

NDC 63561-0203 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerGranulation Technology, Inc.
Marketing categoryUnapproved drug (not FDA-reviewed)
Dosage form / routeTABLET · ORAL
Active ingredientsHYOSCYAMINE SULFATE (.125 mg/1)
Marketing started20260727
Package count1

External sources

Source: openFDA. Public-domain (CC0).